abstract |
The present invention relates to compounds of the formula (I), wherein R1 to R7, X and Y are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors. |